Correlation Between Energenesis Biomedical and WIN Semiconductors

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Energenesis Biomedical and WIN Semiconductors at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Energenesis Biomedical and WIN Semiconductors into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Energenesis Biomedical Co and WIN Semiconductors, you can compare the effects of market volatilities on Energenesis Biomedical and WIN Semiconductors and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Energenesis Biomedical with a short position of WIN Semiconductors. Check out your portfolio center. Please also check ongoing floating volatility patterns of Energenesis Biomedical and WIN Semiconductors.

Diversification Opportunities for Energenesis Biomedical and WIN Semiconductors

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Energenesis and WIN is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Energenesis Biomedical Co and WIN Semiconductors in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WIN Semiconductors and Energenesis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Energenesis Biomedical Co are associated (or correlated) with WIN Semiconductors. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WIN Semiconductors has no effect on the direction of Energenesis Biomedical i.e., Energenesis Biomedical and WIN Semiconductors go up and down completely randomly.

Pair Corralation between Energenesis Biomedical and WIN Semiconductors

Assuming the 90 days trading horizon Energenesis Biomedical Co is expected to generate 0.91 times more return on investment than WIN Semiconductors. However, Energenesis Biomedical Co is 1.09 times less risky than WIN Semiconductors. It trades about 0.02 of its potential returns per unit of risk. WIN Semiconductors is currently generating about -0.12 per unit of risk. If you would invest  5,150  in Energenesis Biomedical Co on September 18, 2024 and sell it today you would earn a total of  70.00  from holding Energenesis Biomedical Co or generate 1.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Energenesis Biomedical Co  vs.  WIN Semiconductors

 Performance 
       Timeline  
Energenesis Biomedical 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Energenesis Biomedical Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Energenesis Biomedical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
WIN Semiconductors 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days WIN Semiconductors has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Energenesis Biomedical and WIN Semiconductors Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Energenesis Biomedical and WIN Semiconductors

The main advantage of trading using opposite Energenesis Biomedical and WIN Semiconductors positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Energenesis Biomedical position performs unexpectedly, WIN Semiconductors can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WIN Semiconductors will offset losses from the drop in WIN Semiconductors' long position.
The idea behind Energenesis Biomedical Co and WIN Semiconductors pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements